Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.
D A Hardman, … , J P Kane, M J Malloy
D A Hardman, … , J P Kane, M J Malloy
Published November 1, 1991
Citation Information: J Clin Invest. 1991;88(5):1722-1729. https://doi.org/10.1172/JCI115490.
View: Text | PDF
Research Article Article has an altmetric score of 3

Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.

  • Text
  • PDF
Abstract

We have previously described a disorder, normotriglyceridemic abetalipoproteinemia, that is characterized by the virtual absence of plasma low density lipoproteins and complete absence of apoB-100, but with apparently normal secretion of triglyceride-rich lipoproteins containing apoB-48. The patient's plasma lipoproteins were shown on polyacrylamide gels and by antibody mapping to have a new truncated apoB variant, apoB-50, circulating along with her apoB-48. We have found this individual to be homozygous for a single C-to-T nucleotide substitution at apoB codon 2252, which produces a premature in-frame stop codon. Thus, this is a rare example of homozygous hypobetalipoproteinemia. Electron photomicrographs revealed that the diameters of particles in the d less than 1.006 g/ml lipoprotein fraction, in both the postprandial and postabsorptive state, are bimodally distributed. The molar ratio of apoE to apoB in these particles is 3.5:1, similar to normal VLDL. The plasma LDL interval contains both spherical and cuboidal particles. Autologous reinfusion of labeled d less than 1.006 g/ml lipoproteins showed exponential disappearance from plasma, with an apparent half-removal time of 50 min, somewhat slower than for normal chylomicrons but within the normal range for VLDL. The calculated production rate for apoB was within the normal range in this subject. A very small amount of label was found briefly in the IDL fraction, but none at any time in LDL or HDL. Therefore, because LDL particles that contain apoB-50 lack the putative ligand domain of the LDL receptor, we conclude that the very low level of LDL is due to the rapid removal of the abnormal VLDL particles before their conversion to LDL can take place.

Authors

D A Hardman, C R Pullinger, R L Hamilton, J P Kane, M J Malloy

×

Total citations by year

Year: 2022 2021 2015 2014 2012 2011 2009 2008 2007 2006 2005 2003 2002 2001 1999 1998 1997 1996 1995 1994 1993 1992 Total
Citations: 1 1 2 3 1 1 1 1 1 2 3 1 1 1 1 1 2 4 4 2 4 3 41
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (41)

Title and authors Publication Year
Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events.
Mango G, Osti N, Udali S, Vareschi A, Malerba G, Giorgetti A, Pizzolo F, Friso S, Girelli D, Olivieri O, Castagna A, Martinelli N
2022
Normal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene
M Takahashi, N Ozaki, S Nagashima, T Wakabayashi, S Iwamoto, S Ishibashi
Journal of Clinical Lipidology 2021
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
R Schiffmann
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 2015
Homozygous familial hypobetalipoproteinemia: Two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature
AB Cefalù, GD Norata, DG Ghiglioni, D Noto, P Uboldi, K Garlaschelli, A Baragetti, R Spina, V Valenti, C Pederiva, E Riva, L Terracciano, A Zoja, L Grigore, MR Averna, AL Catapano
Atherosclerosis 2015
Insights from human congenital disorders of intestinal lipid metabolism
E Levy
Journal of lipid research 2014
Rapid Development of Atherosclerosis in the World’s Smallest Microminipig Fed a High-Fat/High-Cholesterol Diet
H Kawaguchi, T Yamada, N Miura, M Ayaori, H Uto-Kondo, M Ikegawa, M Noguchi, KY Wang, H Izumi, A Tanimoto
Journal of Atherosclerosis and Thrombosis 2014
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia
MD Filippo, P Moulin, P Roy, ME Samson-Bouma, S Collardeau-Frachon, S Chebel-Dumont, N Peretti, J Dumortier, F Zoulim, T Fontanges, R Parini, M Rigoldi, F Furlan, G Mancini, D Bonnefont-Rousselot, E Bruckert, J Schmitz, JY Scoazec, S Charrière, S Villar-Fimbel, F Gottrand, B Dubern, D Doummar, F Joly, ME Liard-Meillon, A Lachaux, A Sassolas
Journal of Hepatology 2014
Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
MC Lam, J Singham, RA Hegele, M Riazy, MA Hiob, G Francis, UP Steinbrecher
Case reports in gastroenterology 2012
Handbook of Clinical Neurology
T Ashizawa, PS Sarkar
Muscular Dystrophies 2011
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia
M Najah, ED Leo, J Awatef, L Magnolo, J Imene, E Pinotti, M Bahri, S Barsaoui, I Brini, M Fekih, MN Slimane, P Tarugi
Clinica Chimica Acta 2009
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations
ED Leo, L Magnolo, M Bertolotti, M Bourbon, SC Pereira, M Pirisi, S Calandra, P Tarugi
Clinical Genetics 2008
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?
JR Burnett, GF Watts
Expert Opinion on Therapeutic Targets 2007
Physiology of the Gastrointestinal Tract
DJ Drucker
Physiology of the Gastrointestinal Tract 2006
Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies
KG Parhofer, PH Barrett
Journal of lipid research 2006
Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia
VM Homer, PM George, SD Toit, JS Davidson, CJ Wilson
Annals of Neurology 2005
Monogenic Hypocholesterolaemic Lipid Disorders and Apolipoprotein B Metabolism
AJ Hooper, FM van Bockxmeer, JR Burnett
Critical Reviews in Clinical Laboratory Sciences 2005
Optic atrophies in metabolic disorders
M Huizing, BP Brooks, Y Anikster
Molecular Genetics and Metabolism 2005
Familial hypobetalipoproteinemia: a review
G Schonfeld
Journal of lipid research 2003
Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits
F Apostel, R Dammann, GP Pfeifer, J Greeve
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2002
Donor Splice-Site Mutation (210+1G_C) in the ApoB Gene Causes a Very Low Level of ApoB-100 and LDL Cholesterol
FK Welty, KA Guida, JJ Andersen
Arteriosclerosis, thrombosis, and vascular biology 2001
Hammerhead Ribozyme Cleavage of Apolipoprotein B mRNA Generates a Truncated Protein
JP Wang, M Enjoji, M Tiebel, S Ochsner, L Chan, BB Teng
The Journal of biological chemistry 1999
A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus
K Ohashi, S Ishibashi, M Yamamoto, J Osuga, Y Yazaki, S Yukawa, N Yamada
Arteriosclerosis, thrombosis, and vascular biology 1998
Organ Loci of Catabolism of Short Truncations of ApoB
XF Zhu, D Noto, R Seip, A Shaish, G Schonfeld
Arteriosclerosis, thrombosis, and vascular biology 1997
Amino terminus of apolipoprotein B suffices to produce recognition of malondialdehyde-modified low density lipoprotein by the scavenger receptor of human monocyte-macrophages
J Kreuzer, AL White, TJ Knott, ML Jien, M Mehrabian, J Scott, SG Young, ME Haberland
Journal of lipid research 1997
Hepatic Expression of the Catalytic Subunit of the Apolipoprotein B mRNA Editing Enzyme (apobec-1) Ameliorates Hypercholesterolemia in LDL Receptor-Deficient Rabbits
KF Kozarsky, DK Bonen, F Giannoni, T Funahashi, JM Wilson, NO Davidson
Human Gene Therapy 1996
A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: Genetic and metabolic studies
N Srivastava, D Noto, M Averna, J Pulai, RA Srivastava, TG Cole, MA Latour, BW Patterson, G Schonfeld
Metabolism 1996
Homozygous Familial Hypobetalipoproteinemia: Increased LDL Catabolism in Hypobetalipoproteinemia Due to a Truncated Apolipoprotein B Species, Apo B-87 Padova
C Gabelli, C Bilato, S Martini, GE Tennyson, LA Zech, A Corsini, M Albanese, HB Brewer, G Crepaldi, G Baggio
Arteriosclerosis, thrombosis, and vascular biology 1996
Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits
J Greeve, VK Jona, NR Chowdhury, MS Horwitz, JR Chowdhury
Journal of lipid research 1996
Apoprotein B-100 Production Is Decreased in Subjects Heterozygous for Truncations of Apoprotein B
CA Aguilar-Salinas, PH Barrett, KG Parhofer, SG Young, D Tessereau, J Bateman, C Quinn, G Schonfeld
Arteriosclerosis, thrombosis, and vascular biology 1995
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti
1995
Molekularbiologische Grundlagen der Gastroenterologie
HG Beger, MP Manns, H Greten
1995
THE MOLECULAR BASIS OF INHERITED DISORDERS OF THE GASTROINTESTINAL AND HEPATOBILIARY TRACTS
MG Martín, E Turk
Gastroenterology Clinics of North America 1995
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia
PJ Talmud, ES Krul, M Pessah, G Gay, G Schonfeld, SE Humphries, R Infante
Journal of lipid research 1994
Human Apolipoprotein Mutants III
CR Sirtori, G Franceschini, BH Brewer
1993
Familial hypobetalipoproteinemia
MF Linton, RV Farese, SG Young
Journal of lipid research 1993
Four new mutations in the apolipoprotein B gene causing hypobetalipoproteinemia, including two different frameshift mutations that yield truncated apolipoprotein B proteins of identical length
SG Young, CR Pullinger, BR Zysow, H Hofmann-Radvani, MF Linton, RV Farese, JF Terdiman, SM Snyder, SM Grundy, GL Vega
Journal of lipid research 1993
Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins
J Greeve, I Altkemper, JH Dieterich, H Greten, E Windler
Journal of lipid research 1993
Two apolipoprotein B gene defects in a kindred with hypobetalipoproteinemia, one of which results in a truncated variant, apoB-61, in VLDL and LDL
CR Pullinger, E Hillas, DA Hardman, GC Chen, JM Naya-Vigne, JA Iwasa, RL Hamilton, JM Lalouel, RR Williams, JP Kane
Journal of lipid research 1992
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism
MG Traber, GW Burton, L Hughes, KU Ingold, H Hidaka, M Malloy, J Kane, J Hyams, HJ Kayden
Journal of lipid research 1992
ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies
ES Krul, KG Parhofer, PH Barrett, RD Wagner, G Schonfeld
Journal of lipid research 1992

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
12 readers on Mendeley
See more details